RSPI Insider Trading Activity and SEC Form 4 Filings
RSPI insider trading summary
No open-market insider purchases or sales of RespireRx Pharmaceuticals Inc. (RSPI) have been reported on SEC Form 4 in the past 12 months.
Latest RSPI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 12, 2018 | Arnold Lippa | Exec Chairman, CSO | Buy | $0 (47,620 @ $0.00) |
| Sep 13, 2017 | James S J Manuso | President and CEO | Buy | $0 (1,097 @ $0.00) |
| Sep 14, 2015 | Jeff Eliot Margolis | VP, Treasurer & Secretary | Sell | $0 (483,872 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.